Peter Lee, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12988 68th St Se, Lisbon, ND 58054 Phone: 701-680-1298 |
Patricia Well Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 407 Main St, Lisbon, ND 58054 Phone: 701-683-5282 |
Dr. Jill Marie Mcritchie, PHARM.D., R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1400 Rose St, Lisbon, ND 58054 Phone: 701-683-6516 Fax: 701-683-6545 |
Kara Tuhy, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 404 Main St, Lisbon, ND 58054 Phone: 701-683-4691 |
Dr. Cody Jonathan Behm, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 404 Main St, Lisbon, ND 58054 Phone: 701-683-4691 Fax: 701-683-4550 |
Susan Marie Long, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 407 Main St, Lisbon, ND 58054 Phone: 704-683-5282 Fax: 701-683-5218 |
Mandy Binstock, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1600 Veterans Dr, Lisbon, ND 58054 Phone: 701-683-6514 |
News Archive
Exposure to air pollution and road traffic noise over the course of many years may be associated with an increased risk of developing heart failure, and the correlation appears to be even greater in people who are former smokers or have high blood pressure, according to new research published today in the Journal of the American Heart Association, an open access journal of the American Heart Association.
Varian Medical Systems is spotlighting its new TrueBeamâ„¢ medical linear accelerator for fast, powerful and efficient cancer treatments at the European Society for Therapeutic Radiology and Oncology exhibition in Barcelona next week. A fully-featured TrueBeam system will be the centerpiece of Varian's booth at the annual ESTRO meeting (Booth No. 320).
BioScale, an innovative life science company that develops, manufactures and promotes novel analytical tools enabling advancements in protein research, announced that results from the analysis of two pharmacodynamic biomarkers using the Acoustic Membrane MicroParticles assay technology on the ViBE Protein Analysis Workstation were published in the peer-reviewed Elsevier Journal of Analytical Biochemistry.
Plexxikon, Inc., announced today that it has signed an agreement with Genentech to co-promote PLX4032 (RG7204) in the United States. PLX4032, an oral, novel kinase inhibitor that targets the oncogenic BRAF mutation, is being tested in late-stage clinical trials for the treatment of metastatic melanoma.
› Verified 3 days ago